Alzheimer's Disease Trial, Recruiting NCT06595511 Sponsor: Istanbul Medipol University Hospital Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06595511
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

For people with Alzheimer's disease:

  • People who have been formally diagnosed with Alzheimer's disease using recognised diagnostic standards
  • People who have some difficulty with everyday tasks such as dressing, cooking, or managing finances
  • People whose disease falls within a mild-to-moderate range, based on specific memory and thinking test scores (CDR score of 1–2 and MMSE score of 15–26)
  • People who have been on a stable dose of memory-related or other brain-affecting medications
  • People between the ages of 60 and 86 who have had at least 5 years of schooling or education

For healthy older adults:

  • People between the ages of 60 and 86
  • People with no known neurological conditions or general problems with memory and thinking (MMSE score above 25)
  • People who have not been diagnosed with a neurological or psychiatric condition
  • People who are not taking any neurological or psychiatric medications

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

For people with Alzheimer's disease:

  • People whose dementia is a type other than Alzheimer's disease, such as frontotemporal dementia, vascular dementia, or Lewy body dementia
  • People who have Parkinson's disease, clinical depression, other mental health conditions, epilepsy, drug or alcohol addiction, or a history of serious brain injury

For healthy older adults:

  • People who show signs of any type of cognitive impairment, including mild cognitive impairment, Alzheimer's disease, Parkinson's disease, Lewy body dementia, or frontotemporal dementia
  • People who have epilepsy, alcohol or drug addiction, a history of serious brain injury, or who take any medications known to affect memory or thinking

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +90 5326031560

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istanbul Medipol University Hospital
Registry
ClinicalTrials.gov
Start date
1 October 2022
Est. completion
30 September 2024

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

EEG recording

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov